Apyx Medical Co. (NASDAQ:APYX) Short Interest Update

Apyx Medical Co. (NASDAQ:APYX) was the recipient of a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 140,500 shares, a drop of 39.0% from the October 31st total of 230,300 shares. Based on an average trading volume of 42,400 shares, the short-interest ratio is currently 3.3 days. Approximately 0.5% of the shares of the stock are sold short.

Apyx Medical Trading Down 4.7 %

APYX traded down $0.08 during trading on Friday, hitting $1.61. 64,749 shares of the stock traded hands, compared to its average volume of 80,941. The business has a 50 day moving average price of $1.27 and a 200 day moving average price of $1.33. Apyx Medical has a twelve month low of $0.97 and a twelve month high of $2.80. The company has a quick ratio of 4.52, a current ratio of 5.46 and a debt-to-equity ratio of 3.03.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings results on Friday, November 8th. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. The company had revenue of $11.49 million during the quarter, compared to analysts’ expectations of $11.66 million. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. During the same quarter in the previous year, the firm earned ($0.13) EPS. As a group, sell-side analysts anticipate that Apyx Medical will post -0.68 EPS for the current year.

Hedge Funds Weigh In On Apyx Medical

Institutional investors have recently added to or reduced their stakes in the stock. Royce & Associates LP boosted its position in Apyx Medical by 3.4% in the third quarter. Royce & Associates LP now owns 2,582,490 shares of the company’s stock valued at $3,202,000 after buying an additional 85,267 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of Apyx Medical by 2.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 511,561 shares of the company’s stock valued at $685,000 after acquiring an additional 14,481 shares in the last quarter. Private Advisor Group LLC boosted its holdings in shares of Apyx Medical by 3.9% during the 3rd quarter. Private Advisor Group LLC now owns 322,321 shares of the company’s stock valued at $400,000 after acquiring an additional 12,180 shares in the last quarter. Rathbones Group PLC grew its position in Apyx Medical by 148.0% during the 2nd quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock worth $337,000 after acquiring an additional 150,000 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new position in Apyx Medical in the 2nd quarter worth about $101,000. 55.33% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. Craig Hallum upgraded Apyx Medical to a “strong-buy” rating in a research report on Thursday, October 24th. JMP Securities reaffirmed a “market perform” rating on shares of Apyx Medical in a research report on Monday, September 16th. Finally, BTIG Research started coverage on shares of Apyx Medical in a research note on Thursday, October 17th. They set a “neutral” rating on the stock.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.